NCAM1 and breast cancer: If MICA and CD56 play a role in breast cancer immunosurveillance, it is possible that in older women, immunosurveillance underperformance stems predominantly not from a decrease in the density of CD56+ NK cells, but a decrease in the cytotoxicity of CD56+ NK cells as a result of decreased activation by MICA.